Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Veltkamp

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Neurological Research and Practice|February 11, 2025
Association of oral anticoagulants with risk of brain haemorrhage expansion compared to no-anticoagulationRoland Veltkamp, Kirsten Haas, Viktoria Rücker, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 29, 2018
Expert opinion paper on atrial fibrillation detection after ischemic strokeKarl Georg Haeusler, Klaus Gröschel, Martin Köhrmann, et al.
Thrombosis and Haemostasis|December 31, 2024
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF TrialEleni Korompoki, Peter Heuschmann, Kirsten H Harvey, et al.
Neurology|November 10, 2017
Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AFAndreas Charidimou, Christopher Karayiannis, Tae-Jin Song, et al.
The Lancet. Neurology|October 15, 2023
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trialsRustam Al-Shahi Salman, Jacqueline Stephen, Jayne F Tierney, et al.
Lancet (London, England)|September 5, 2022
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trialAshkan Shoamanesh, Hardi Mundl, Eric E Smith, et al.
The New England Journal of Medicine|August 27, 2021
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNicolas M Van Mieghem, Martin Unverdorben, Christian Hengstenberg, et al.
Neurology|April 7, 2017
Outcome of intracerebral hemorrhage associated with different oral anticoagulantsDuncan Wilson, David J Seiffge, Christopher Traenka, et al.
Annals of Neurology|April 11, 2015
Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhageAdrian R Parry-Jones, Mario Di Napoli, Joshua N Goldstein, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Neurological Research and Practice|February 11, 2025
Association of oral anticoagulants with risk of brain haemorrhage expansion compared to no-anticoagulationRoland Veltkamp, Kirsten Haas, Viktoria Rücker, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 29, 2018
Expert opinion paper on atrial fibrillation detection after ischemic strokeKarl Georg Haeusler, Klaus Gröschel, Martin Köhrmann, et al.
Thrombosis and Haemostasis|December 31, 2024
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF TrialEleni Korompoki, Peter Heuschmann, Kirsten H Harvey, et al.
Neurology|November 10, 2017
Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AFAndreas Charidimou, Christopher Karayiannis, Tae-Jin Song, et al.
The Lancet. Neurology|October 15, 2023
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trialsRustam Al-Shahi Salman, Jacqueline Stephen, Jayne F Tierney, et al.
Lancet (London, England)|September 5, 2022
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trialAshkan Shoamanesh, Hardi Mundl, Eric E Smith, et al.
The New England Journal of Medicine|August 27, 2021
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNicolas M Van Mieghem, Martin Unverdorben, Christian Hengstenberg, et al.
Neurology|April 7, 2017
Outcome of intracerebral hemorrhage associated with different oral anticoagulantsDuncan Wilson, David J Seiffge, Christopher Traenka, et al.
Annals of Neurology|April 11, 2015
Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhageAdrian R Parry-Jones, Mario Di Napoli, Joshua N Goldstein, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
Pageof 20